Physician profile
Douglas Minton
NPI 1174697023
$5,456.99
in general payments reported to CMS, 2019-2025
35 companies · $83.86 in 2025
The $83.86 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,959 · 2020: $316 · 2021: $936 · 2022: $1,506 · 2023: $585 · 2024: $70.98 · 2025: $83.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,078.11 | 2019-2021 | |
| Momentis Surgical INC. | $875.00 | 2022 | |
| Abbvie INC. | $521.84 | 2019-2024 | |
| Allergan, INC. | $317.41 | 2019-2022 | |
| Astellas Pharma US INC | $167.35 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $162.00 | 2021-2025 | |
| Hologic Sales and Service, LLC | $151.92 | 2019-2023 | Acessa Provu System, Myosure Tissue Removal Device |
| Evofem Biosciences, INC. | $129.24 | 2021-2022 | |
| Coopersurgical, INC. | $126.30 | 2019-2023 | Paragard T 380a |
| Exeltis, USA INC. | $109.84 | 2020-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $87.54 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $83.44 | 2023-2025 | Myfembree, Gemtesa |
| Organon LLC | $72.04 | 2021-2022 | |
| Pfizer INC. | $66.92 | 2023 | |
| Therapeuticsmd, INC. | $59.02 | 2019-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $57.10 | 2023-2025 | Truclear |
| Baxter Healthcare | $45.61 | 2020 | |
| Avion Pharmaceuticals | $39.49 | 2021-2022 | |
| Myovant Sciences INC. | $32.14 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $29.19 | 2021 | |
| Meditrina | $25.54 | 2021 | |
| Roche Diagnostics Corporation | $21.17 | 2021 | |
| Coloplast Corp | $20.80 | 2022 | |
| Mallinckrodt Enterprises LLC | $20.00 | 2019 | |
| Smith+Nephew, INC. | $18.87 | 2023 | Grafix Pl |
| Amgen INC. | $17.72 | 2020 | |
| Merz North America, INC. | $17.12 | 2022 | |
| Exact Sciences Corporation | $16.58 | 2023 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $14.33 | 2024 | |
| Amag Pharmaceuticals, INC. | $13.74 | 2019 | |
| Avanos Medical | $13.28 | 2019 | |
| Agile Therapeutics, INC. | $12.91 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.69 | 2019 | |
| Merck Sharp & Dohme LLC | $12.43 | 2019 | |
| Alydia Health | $8.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Minton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.